liraglutide and semaglutide market GLP-1 Receptor Agonist Growth Analysis Liraglutide Market Size, Share, Analysis

Less common but more serious risks include: Pancreatitis, which can cause severe abdominal pain and may require stopping the medication Gallbladder problems, such as gallstones or inflammation, especially with higher doses or longer use Allergic reactions, including swelling or difficulty breathing, which need immediate medical attention Injection site reactions, such as redness or itching, with injectable forms Rare vision changes or worsening diabetic eye disease, especially when blood sugar improves rapidly Anyone with intense abdominal pain, signs of dehydration (such as dizziness or reduced urination), or unexpected vision changes should seek medical advice promptly

Either option can work

Mild reactions are common: rash, nausea, headache

Long-term activation of glucagon-like peptide-1 receptor by dulaglutide prevents diabetic heart failure and metabolic remodeling in type 2 diabetes

211 Similarly, metabolic bariatric surgery has limited availability in the vast majority of Australian public hospitals, with more than 90% of procedures taking place in the private sector

There is no clinical trial comparing the two directly